Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 70 Women only

Fecal microbiota transplantation for treating irritable bowel syndrome

Official title: Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)

Run by Mayo Clinic · NCT05776914 · Data updated 2026-11-12

This study is testing if using stool from a healthy donor can help people with irritable bowel syndrome feel better by restoring a healthy balance of gut bacteria.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment43 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedApril 15, 2024
Main results expectedJune 26, 2027
Study endsJune 26, 2027
Registry record updatedMay 8, 2026
Trial IDNCT05776914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with moderate to severe irritable bowel syndrome who meet specific inclusion criteria.

Probably not a fit

Patients with severe bowel or medical diseases, immune deficiencies, or those who are pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity, specifically targeting patients with irritable bowel syndrome (IBS) characterized by high proteolytic activity. Participants will undergo either donor or autologous FMT to assess improvements in their IBS symptoms. The study focuses on individuals with moderate to severe symptoms as defined by established criteria. The approach seeks to restore a healthy gut microbiome to alleviate IBS symptoms.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from irritable bowel syndrome.

How similar studies have gone: Other studies have shown promising results with fecal microbiota transplantation for gastrointestinal disorders, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* IBS defined by Rome IV criteria
* Non IBS-C
* Moderate to severe symptoms defined by IBS-SSS≥175
* Able to safely undergo and consent to colonoscopy

Exclusion Criteria

* Immune deficiency or treatment with immunosuppressive medications
* Severe bowel or medical disease precluding administration of bowel prep
* Severe bowel or medical disease precluding colonoscopy with conscious sedation
* Active cancer
* Pregnant or lactating
* Abdominal surgery (exception of splenectomy, partial hepatectomy, partial/unilateral nephrectomy, laparoscopy, pelvic floor repair, mesh, liposuction, fundoplication, tubal ligation, gastric sleeve, oophorectomy, hernia, appendectomy, cholecystectomy, caesarean section and hysterectomy)
* Severe psychiatric disorder (HADS-A or D\>16), or diagnosed alcohol or drug abuse disorder
* New probiotics or treatment with antibiotics, NSAIDs (within 4 wks prior to study entry)
* Use of treatments known to affect colonic motility (with exception of loperamide)
* Diagnosed h/o bleeding disorder
* Organic GI diseases (IBD, celiac disease, microscopic colitis)
* Chronic kidney or liver disease
* Absolute neutrophil count (ANC) \<500 IU/ml

Where it's running

  • Mayo Clinic in Minnesota
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.